Illuminating metabolism: A pioneering approach to combat pancreatic cancer
Costas Lyssiotis, PhD, received the 2013 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant, 2016 AACR-Bayer Innovation and Discovery Award, and 2017 AACR NextGen Grant for Transformative Cancer Research. Dr. Lyssiotis shares how these three AACR grants helped him and his team discover several mechanisms by which metabolites support tumor growth, immune evasion, and resistance to therapy in pancreatic cancer.